Free Trial
→ The investigation Porter spent tens of thousands to document (From Porter & Company) (Ad)tc pixel Free CVS Stock Alerts

CVS Health (CVS) Competitors

CVS Health logo
$86.30 -0.71 (-0.81%)
Closing price 03:59 PM Eastern
Extended Trading
$86.14 -0.16 (-0.19%)
As of 04:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

CVS vs. AMZN, WMT, CI, ELV, and HUM

Should you buy CVS Health stock or one of its competitors? CVS Health's main competitors and comparable companies include Amazon.com (AMZN), Walmart (WMT), Cigna Group (CI), Elevance Health (ELV), and Humana (HUM). Companies are selected based on similarities in market, industry, and size.

How does CVS Health compare to Amazon.com?

CVS Health (NYSE:CVS) and Amazon.com (NASDAQ:AMZN) are related large-cap companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, profitability, analyst recommendations, risk, valuation and dividends.

80.7% of CVS Health shares are owned by institutional investors. Comparatively, 72.2% of Amazon.com shares are owned by institutional investors. 0.9% of CVS Health shares are owned by insiders. Comparatively, 8.9% of Amazon.com shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Amazon.com had 298 more articles in the media than CVS Health. MarketBeat recorded 320 mentions for Amazon.com and 22 mentions for CVS Health. Amazon.com's average media sentiment score of 0.83 beat CVS Health's score of 0.50 indicating that Amazon.com is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVS Health
7 Very Positive mention(s)
4 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Amazon.com
179 Very Positive mention(s)
57 Positive mention(s)
37 Neutral mention(s)
28 Negative mention(s)
16 Very Negative mention(s)
Positive

Amazon.com has higher revenue and earnings than CVS Health. Amazon.com is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVS Health$402.07B0.28$1.77B$3.7823.00
Amazon.com$716.92B3.78$77.67B$12.4320.23

Amazon.com has a net margin of 17.44% compared to CVS Health's net margin of 1.18%. Amazon.com's return on equity of 18.00% beat CVS Health's return on equity.

Company Net Margins Return on Equity Return on Assets
CVS Health1.18% 13.12% 3.95%
Amazon.com 17.44%18.00%8.97%

CVS Health has a beta of 0.6, indicating that its share price is 40% less volatile than the broader market. Comparatively, Amazon.com has a beta of 1.45, indicating that its share price is 45% more volatile than the broader market.

CVS Health presently has a consensus price target of $107.24, indicating a potential upside of 23.35%. Amazon.com has a consensus price target of $321.63, indicating a potential upside of 27.94%. Given Amazon.com's higher possible upside, analysts clearly believe Amazon.com is more favorable than CVS Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVS Health
0 Sell rating(s)
1 Hold rating(s)
22 Buy rating(s)
0 Strong Buy rating(s)
2.96
Amazon.com
0 Sell rating(s)
3 Hold rating(s)
56 Buy rating(s)
0 Strong Buy rating(s)
2.95

Summary

Amazon.com beats CVS Health on 13 of the 16 factors compared between the two stocks.

How does CVS Health compare to Walmart?

Walmart (NASDAQ:WMT) and CVS Health (NYSE:CVS) are related large-cap companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, valuation and risk.

In the previous week, Walmart had 26 more articles in the media than CVS Health. MarketBeat recorded 48 mentions for Walmart and 22 mentions for CVS Health. CVS Health's average media sentiment score of 0.50 beat Walmart's score of 0.45 indicating that CVS Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Walmart
18 Very Positive mention(s)
8 Positive mention(s)
15 Neutral mention(s)
5 Negative mention(s)
0 Very Negative mention(s)
Neutral
CVS Health
7 Very Positive mention(s)
4 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Walmart presently has a consensus target price of $131.74, suggesting a potential upside of 25.38%. CVS Health has a consensus target price of $107.24, suggesting a potential upside of 23.35%. Given Walmart's stronger consensus rating and higher probable upside, analysts plainly believe Walmart is more favorable than CVS Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Walmart
0 Sell rating(s)
4 Hold rating(s)
32 Buy rating(s)
3 Strong Buy rating(s)
2.97
CVS Health
0 Sell rating(s)
1 Hold rating(s)
22 Buy rating(s)
0 Strong Buy rating(s)
2.96

Walmart pays an annual dividend of $0.99 per share and has a dividend yield of 0.9%. CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 3.1%. Walmart pays out 35.7% of its earnings in the form of a dividend. CVS Health pays out 70.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Walmart has increased its dividend for 53 consecutive years and CVS Health has increased its dividend for 4 consecutive years.

26.8% of Walmart shares are held by institutional investors. Comparatively, 80.7% of CVS Health shares are held by institutional investors. 0.1% of Walmart shares are held by insiders. Comparatively, 0.9% of CVS Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Walmart has higher revenue and earnings than CVS Health. CVS Health is trading at a lower price-to-earnings ratio than Walmart, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Walmart$713.16B1.17$21.89B$2.7737.93
CVS Health$402.07B0.28$1.77B$3.7823.00

Walmart has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market. Comparatively, CVS Health has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market.

Walmart has a net margin of 3.00% compared to CVS Health's net margin of 1.18%. Walmart's return on equity of 21.83% beat CVS Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Walmart3.00% 21.83% 7.80%
CVS Health 1.18%13.12%3.95%

Summary

Walmart beats CVS Health on 14 of the 20 factors compared between the two stocks.

How does CVS Health compare to Cigna Group?

Cigna Group (NYSE:CI) and CVS Health (NYSE:CVS) are both large-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

Cigna Group has a beta of 0.29, suggesting that its share price is 71% less volatile than the broader market. Comparatively, CVS Health has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market.

Cigna Group currently has a consensus price target of $338.24, indicating a potential upside of 24.63%. CVS Health has a consensus price target of $107.24, indicating a potential upside of 23.35%. Given Cigna Group's higher probable upside, equities analysts plainly believe Cigna Group is more favorable than CVS Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cigna Group
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65
CVS Health
0 Sell rating(s)
1 Hold rating(s)
22 Buy rating(s)
0 Strong Buy rating(s)
2.96

Cigna Group has a net margin of 2.27% compared to CVS Health's net margin of 1.18%. Cigna Group's return on equity of 19.75% beat CVS Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Cigna Group2.27% 19.75% 5.34%
CVS Health 1.18%13.12%3.95%

Cigna Group has higher earnings, but lower revenue than CVS Health. Cigna Group is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cigna Group$281.34B0.25$5.96B$24.1711.23
CVS Health$402.07B0.28$1.77B$3.7823.00

Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.3%. CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 3.1%. Cigna Group pays out 25.8% of its earnings in the form of a dividend. CVS Health pays out 70.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has increased its dividend for 5 consecutive years and CVS Health has increased its dividend for 4 consecutive years.

In the previous week, Cigna Group had 3 more articles in the media than CVS Health. MarketBeat recorded 25 mentions for Cigna Group and 22 mentions for CVS Health. CVS Health's average media sentiment score of 0.50 beat Cigna Group's score of 0.38 indicating that CVS Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cigna Group
5 Very Positive mention(s)
7 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CVS Health
7 Very Positive mention(s)
4 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

87.0% of Cigna Group shares are held by institutional investors. Comparatively, 80.7% of CVS Health shares are held by institutional investors. 0.6% of Cigna Group shares are held by company insiders. Comparatively, 0.9% of CVS Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Cigna Group beats CVS Health on 10 of the 19 factors compared between the two stocks.

How does CVS Health compare to Elevance Health?

Elevance Health (NYSE:ELV) and CVS Health (NYSE:CVS) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

Elevance Health has a beta of 0.7, suggesting that its share price is 30% less volatile than the broader market. Comparatively, CVS Health has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market.

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 80.7% of CVS Health shares are held by institutional investors. 0.3% of Elevance Health shares are held by insiders. Comparatively, 0.9% of CVS Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Elevance Health has a net margin of 2.47% compared to CVS Health's net margin of 1.18%. Elevance Health's return on equity of 14.64% beat CVS Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.47% 14.64% 5.22%
CVS Health 1.18%13.12%3.95%

Elevance Health has higher earnings, but lower revenue than CVS Health. Elevance Health is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$201.11B0.43$5.66B$22.5017.56
CVS Health$402.07B0.28$1.77B$3.7823.00

In the previous week, CVS Health had 15 more articles in the media than Elevance Health. MarketBeat recorded 22 mentions for CVS Health and 7 mentions for Elevance Health. CVS Health's average media sentiment score of 0.50 beat Elevance Health's score of 0.31 indicating that CVS Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
1 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CVS Health
7 Very Positive mention(s)
4 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 3.1%. Elevance Health pays out 30.6% of its earnings in the form of a dividend. CVS Health pays out 70.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 14 consecutive years and CVS Health has increased its dividend for 4 consecutive years.

Elevance Health currently has a consensus price target of $440.90, suggesting a potential upside of 11.58%. CVS Health has a consensus price target of $107.24, suggesting a potential upside of 23.35%. Given CVS Health's stronger consensus rating and higher possible upside, analysts plainly believe CVS Health is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65
CVS Health
0 Sell rating(s)
1 Hold rating(s)
22 Buy rating(s)
0 Strong Buy rating(s)
2.96

Summary

Elevance Health beats CVS Health on 10 of the 19 factors compared between the two stocks.

How does CVS Health compare to Humana?

Humana (NYSE:HUM) and CVS Health (NYSE:CVS) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings and valuation.

CVS Health has higher revenue and earnings than Humana. CVS Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Humana$145.68B0.33$1.19B$10.5738.35
CVS Health$402.07B0.28$1.77B$3.7823.00

In the previous week, Humana had 2 more articles in the media than CVS Health. MarketBeat recorded 24 mentions for Humana and 22 mentions for CVS Health. Humana's average media sentiment score of 0.54 beat CVS Health's score of 0.50 indicating that Humana is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Humana
5 Very Positive mention(s)
5 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CVS Health
7 Very Positive mention(s)
4 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.9%. CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 3.1%. Humana pays out 33.5% of its earnings in the form of a dividend. CVS Health pays out 70.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. CVS Health has raised its dividend for 4 consecutive years. CVS Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Humana has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market. Comparatively, CVS Health has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

Humana currently has a consensus price target of $408.61, indicating a potential upside of 0.80%. CVS Health has a consensus price target of $107.24, indicating a potential upside of 23.35%. Given CVS Health's stronger consensus rating and higher possible upside, analysts clearly believe CVS Health is more favorable than Humana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Humana
1 Sell rating(s)
14 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.47
CVS Health
0 Sell rating(s)
1 Hold rating(s)
22 Buy rating(s)
0 Strong Buy rating(s)
2.96

92.4% of Humana shares are owned by institutional investors. Comparatively, 80.7% of CVS Health shares are owned by institutional investors. 0.2% of Humana shares are owned by company insiders. Comparatively, 0.9% of CVS Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

CVS Health has a net margin of 1.18% compared to Humana's net margin of 0.88%. CVS Health's return on equity of 13.12% beat Humana's return on equity.

Company Net Margins Return on Equity Return on Assets
Humana0.88% 11.20% 3.94%
CVS Health 1.18%13.12%3.95%

Summary

CVS Health beats Humana on 11 of the 19 factors compared between the two stocks.

Get CVS Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CVS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CVS vs. The Competition

Export
MetricCVS HealthHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$110.22B$9.83B$7.11B$23.00B
Dividend Yield3.08%2.61%2.54%3.73%
P/E Ratio22.8034.00274.0227.97
Price / Sales0.274.76595.4323.10
Price / Cash5.8122.8227.2219.11
Price / Book1.455.1611.174.72
Net Income$1.77B$315.68M$3.49B$1.07B
7 Day Performance-1.02%-0.91%-2.08%0.89%
1 Month Performance-10.99%-2.60%-6.80%-4.97%
1 Year Performance12.10%9.35%5.94%5.73%

CVS Health Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CVS
CVS Health
4.9732 of 5 stars		$86.30
-0.8%		$107.24
+24.3%		+12.2%$110.38B$402.07B22.83300,000
AMZN
Amazon.com
4.9906 of 5 stars		$247.51
-0.7%		$321.63
+29.9%		+14.5%$2.67T$716.92B19.921,576,000
WMT
Walmart
4.8887 of 5 stars		$104.79
+0.8%		$131.74
+25.7%		+2.9%$831.22B$713.16B37.822,100,000
CI
Cigna Group
4.9537 of 5 stars		$267.34
-1.7%		$337.10
+26.1%		-12.8%$70.64B$274.90B11.0667,700
ELV
Elevance Health
4.4701 of 5 stars		$382.81
-1.5%		$440.90
+15.2%		+12.5%$83.02B$199.13B17.0197,100

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:CVS) was last updated on 10/6/2026 by MarketBeat.com Staff.
From Our Partners
Nvidia’s record quarter could send this new type of AI soaring
Nvidia just posted 96.2 billion in revenue for a single quarter, more than Coca-Cola generates in an entire ye...
Brownstone Research | Sponsoredtc pixel
Washington Is Broke—Could YOUR Savings Be Next?
The Department of Justice recently argued in court that cash is not legally property, raising new questions fo...
Priority Gold | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
MILLIONAIRE MASTERCLASS INVITE: Altucher
James Altucher says Elon Musk is preparing an unprecedented project set to surface on December 8th. Altuche...
Paradigm Press | Sponsoredtc pixel
Elon Warns "America Will Go Bankrupt". Trump's Plan Inside.
National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...
American Hartford Gold | Sponsoredtc pixel
A weekly dividend fund holding Nvidia and Palantir
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...
Investors Alley | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Why The Biggest Names in AI Are Heading To The Arctic
Google contracted over 12 GW of energy last year and just announced a 15 billion dollar AI infrastructure inve...
The Tomorrow Investor | Sponsoredtc pixel